JANUS under stress--role of JAK/STAT signaling pathway in vascular diseases

Karsten Grote1, Maren Luchtefeld, Bernhard Schieffer

  • 1Department of Cardiology and Angiology, Medizinische Hochschule Hannover, 30625 Hannover, Germany.

Vascular Pharmacology
|November 8, 2005
PubMed

Insights

The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway is crucial in cardiovascular health. Dysregulation of this pathway contributes to diseases like atherosclerosis and hypertension.

Area of Science:

  • Cardiovascular Biology
  • Molecular Signaling
  • Immunology

Background:

  • The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway, initially identified in immune cells, is now recognized for its role in the cardiovascular system.
  • JAKs and STATs are expressed in the vessel wall, mediating signals from cytokines, growth factors, and vasoactive peptides like angiotensin II.
  • The JAK/STAT pathway's involvement in cardiovascular pathophysiology is suggested by JAKs binding to the angiotensin II type I receptor and modulation by NAD(P)H oxidase.

Purpose of the Study:

  • To review the critical role of the JAK/STAT signaling pathway in cardiovascular disease development.
  • To explore the pathway's involvement in atherosclerotic plaque progression and arterial hypertension.

Main Methods:

  • Review of existing literature on JAK/STAT signaling in cardiovascular research.
  • Analysis of studies investigating JAK-receptor interactions and modulation by reactive oxygen species.
  • Examination of evidence linking JAK/STAT activation to cardiovascular pathologies.

Main Results:

  • JAK/STAT signaling is constitutively expressed in the vessel wall and participates in diverse receptor-mediated signaling.
  • JAKs can directly interact with the angiotensin II type I receptor, influencing cardiovascular responses.
  • NAD(P)H oxidase-derived superoxide anions modulate JAK2 activity, impacting signaling pathways.
  • Activation of JAKs and STATs appears critical for atherosclerotic plaque development.

Conclusions:

  • The JAK/STAT signaling pathway is a significant regulator of cardiovascular disease progression.
  • Understanding JAK/STAT signaling mechanisms is vital for developing therapeutic strategies against atherosclerosis and hypertension.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...